Abstract View

Author(s): Poduri Lakshmi Lohita Priya*1, Syed Tehameem Afzal2, Sheik Arshiya Anjum3

Email(s): 1lohithapoduri@gmail.com

Address:

    PharmD Vikas Institute of Pharmaceutical Sciences, Rajahmundry

Published In:   Volume - 4,      Issue - 7,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.4702  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Diclofenac which is mostly used for pain relief comes under the category of non-steroidal anti-inflammatory drug [NSAID]having the properties of antipyretic, analgesic and anti-inflammatory. It is efficient in inhibiting the prostaglandin synthesis through blockade cyclooxygenase [COX]. It is mainly used to treat pain of mild to moderate and also used in rheumatic diseases. Though it is proficient in treating the pain it is having expeditious adverse effects. These adverse effects show a major effect on the prominent organs like Heart, Liver, GI etc. These undesirable effects can be marked when the diclofenac is used irrationally like GI bleeding, ulceration. In addition to the gastrointestinal problems of ulcers, bleeding, and perforation that arise from unsupervised intake, excessive dosage increases cardiovascular toxicity and the risk of myocardial infarction and stroke. Improper or excessive use can lead to severe organ damage, emphasizing the importance of careful medical oversight when prescribing Diclofenac. Nevertheless, a wealth of research data indicates that diclofenac's pharmacologic effect involves multimodal and, in certain cases, new modes of action in addition to COX inhibition that proves to severe undesirable effects. The negative effects of Diclofenac abuse are critically examined in this study, emphasizing the pressing need for stronger prescribing guidelines, improved regulatory monitoring, and more patient education. To reduce avoidable injury and guarantee safer analgesic usage in clinical practice, these issues must be addressed. Additionally, supporting pharmacovigilance, restricting over-the counter availability, and promoting evidence-based guidelines can all be crucial in reducing the hazards associated with its irrational use.

Cite this article:
Poduri Lakshmi Lohita Priya, Syed Tehameem Afzal, Sheik Arshiya Anjum. An Appraisal On Diclofenac and Its Undesirable Effects: From Pain Relief to Systemic Damage. IJRPAS, July 2025; 4 (7): 13-20.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4702


1.      Skoutakis VA, Carter CA, Mickle TR, Smith VH, Arkin CR, Alissandratos J, et al. 1988. DOI:10.1177/106002808802201102.

2.      Todd PA, Sorkin EM. Diclofenac Sodium. Drugs. 1988;35(3):244–85. https://doi.org/10.2165/00003495-198835030-00004

3.      Altman R, et al. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75(8):859–77. DOI:10.1007/s40265-015-0392-z

4.      Scholer DW, et al. Pharmacology of diclofenac sodium. Am J Med. 1986;80(4B). DOI:10.1016/0002-9343(86)90077-x

5.      Patsnap. What is the mechanism of diclofenac sodium? [Internet]. [cited year unknown]. Available from: https://synapse.patsnap.com/article/what-is-the-mechanism-of-diclofenac-sodium

6.      Davies NM, Anderson KE. Clinical pharmacokinetics of diclofenac: Therapeutic insights and pitfalls. Clinical Pharmacokinetics. 1997;33(3):184–213. DOI:10.2165/00003088-199733030-00003

7.      Clinical Pharmacology in Drug Development. 2018;7(2):110–22. DOI:10.2165/00003088-199733030-00003

8.      Mayo Clinic. Diclofenac (oral route) [Internet]. [cited year unknown]. Available from: https://www.mayoclinic.org/drugs-supplements/diclofenac-oral-route/drg-20069748

9.      Mazzone M, Siciliano M, Carella G. Multiple diclofenac-induced adverse effects. Am J Gastroenterol. 2000;95(10):2988–9. DOI:10.1111/j.1572-0241.2000. 03218.x

10.  Jevdjevic M, et al. The effects of diclofenac and ibuprofen on heart function and oxidative stress markers in the isolated rat heart. Exp Appl Biomed Res. 2014;15(1):11–9. https://doi.org/10.2478/sjecr-2014-0002

11.  Schoen RT, Vender RJ. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med. 1989;86(4). https://doi.org/10.1016/0002-9343(89)90344-6

12.  Boelsterli UA. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 2003;192(3). https://doi.org/10.1016/S0041-008X(03)00368-5

13.  Yasmeen T, Qureshi GS, Perveen S. Adverse effects of diclofenac sodium on renal parenchyma of adult albino rats. J Pak Med Assoc. 2007.

14.  Hernández-Díaz S, Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;160(14):2093–9. DOI:10.1001/archinte.160.14.2093

15.  McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10(2): e1001388. DOI:10.1371/journal.pmed.1001388

16.  Björnsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacology Ther. 2006;79(6):521–8. DOI:10.1016/j.clpt.2006.02.012

17.  Gomaa S. Adverse effects induced by diclofenac, ibuprofen, and paracetamol toxicity on immunological and biochemical parameters in Swiss albino mice. J Basic Appl Zool. 2018;79:5. https://doi.org/10.1186/s41936-018-0025-7

 

Related Images:



Recent Images



Quality by Design Based Analytical Method Development and Validation of Sitagliptin Phosphate by RP-HPLC
An Appraisal On Diclofenac and Its Undesirable Effects: From Pain Relief to Systemic Damage
Novel Approach In Treatment of Cholangiocarcinoma: A Review
High Performance Thin Layer Chromatography method for estimation of Rosuvastatin Calcium and Teneligliptin Hydrobromide Hydrate from its tablet dosage form
Formulation, Development and Evaluation of NDDS Formulation for Treatment of Parkinson’s Disease
A Systematic Review of Cyperus rotundus Linn as an Massive Source of Pharmacologically Active Phyto-Medicine
Miraculous Moringa: A Comprehensive Explanation of its Botanical, Nutritional and Medicinal Potentials
Phytochemical Screening, Formulation and Evaluation of Leaf Extract of Leucas aspera and Leucas indica by Using Analytical Methods
RPHPLC Method for Concurrent Determination of Haloperidol and Trihexyphenidyl in API and Combined Tablet Formulations
A review on HPLC Methods for Estimation of Travoprost  in Combined and Single Pharmaceutical formulation and Bulk

Tags


Recomonded Articles:

Author(s): Bhagyashri C. Patel; Sandhya R. Chavhan; H.P. Suryawanshi; R. A. Ahirrao

DOI:         Access: Open Access Read More

Author(s): Soni Rishita1*, Salunke Khushi1, Patel Harsh1, Patel Aastha1, Taufik Mulla2, Ambika Nand Jha3

DOI:         Access: Open Access Read More

Author(s): Shah Kaunen; Pathan Ahemad; Shah Sahil; Khatik Ali; Abdul Kashif; Abu Asim Azmi

DOI:         Access: Open Access Read More

Author(s): Girisha Chaudhari;Sofiya Morris; Dr. Ashish Jain

DOI:         Access: Open Access Read More

Author(s): Mehul P. Bagde; Mukesh Rajpurohit; Lalit Chaudhary

DOI:         Access: Closed Access Read More

Author(s): Mudigonda Sowjanya*; Nishad, Fariya; Malla Rajeshwari; Dr. K. Lakshmi Surekha

DOI:         Access: Open Access Read More

Author(s): Mohammad Zaid*; Prof. Imran Kalam; Dr. Quazi Majaz

DOI:         Access: Open Access Read More

Author(s): Kazi Kaif Aarefoddin; Mohommad Altamash*; Abdullah Danish

DOI: https://doi.org/10.71431/IJRPAS.2025.4313         Access: Open Access Read More

Author(s): Museb shaikh Mukhtar; Khalifa Mahmadasif Y; Pathan Ayyaj Magbul; Shaikh Faisal; Shaikh Aman; MD Moiz, Shaikh Arbaj.

DOI:         Access: Open Access Read More

Author(s): Patel Azba Siddiq*; Jain Samiksha Kirtikumar; Patel Samiya Mustak Ali

DOI: https://doi.org/10.71431/IJRPAS.2025.4210         Access: Open Access Read More

Author(s): Sayed Saziya F; Khan Afreen; Bushra Fatema; Choudary Sumaiya

DOI:         Access: Open Access Read More

Author(s): Mohammad Aabid, Mohd Zaid Abdul Kaleem, Momin Fatema Zohra Mohd Ateequr Rehman

DOI:         Access: Open Access Read More

Author(s): Baburao Mohite; Manisha Mane; Sarika Suryavanshi; Shrirang Kharmate; Pranali Patil; Anand Gadad.

DOI:         Access: Open Access Read More

Author(s): Bagwan Shahid; Abdul Basit; Khorajia Mohammad; Shah Adnan Wasi; Ansari Arqam

DOI:         Access: Open Access Read More

Author(s): Ankitha .V1;Narendra Reddy. A1; Yalmaji .21Madhu Harika. B1*

DOI: https://doi.org/10.71431/IJRPAS.2025.4206         Access: Open Access Read More

Author(s): Shaikh Shoeb; Mohammad Huzaifa; Bagwan Saman

DOI:         Access: Open Access Read More

Author(s): Memon Mantasha Riyaz*; Mamaniyat Samiha M

DOI: https://doi.org/10.71431/IJRPAS.2025.4209         Access: Open Access Read More

Author(s): Dr. Rahane Rahulkumar; Pawar Pravinkumar; Nagare Siddhant*; More Karishma ; Prof. Kadam Vaibhav; Musale Yogesh.

DOI: https://doi.org/10.71431/IJRPAS.2025.4315         Access: Open Access Read More

Author(s): Harshal G. Patil*, Vinit S. Khairnar

DOI: https://doi.org/10.71431/IJRPAS.2025.4503         Access: Open Access Read More

Author(s): Noor Mohammad Shaikh*; Shaikh Muzammil; Shaikh Mohammad Sofi Ali

DOI: https://doi.org/10.71431/IJRPAS.2025.4405         Access: Open Access Read More